Health News Releases

July 20, 2020 14:10

World’s First Phase III Clinical Trial of COVID-19 Inactivated Vaccine Begins in UAE

The first WHO enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat COVID-19 has started in Abu Dhabi, inspired by the UAE Leadership’s commitment to overcome the

July 17, 2020 11:40

LintonPharm Announces Authorization From China Health Authority to Proceed With a Global Phase 3 Trial Evaluating Catumaxomab in Advanced Gastric Cancer

LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T-cell engaging bispecific antibodies for cancer immunotherapy, today announced the China Nat

July 16, 2020 10:06

European Commission approves third nintedanib indication in pulmonary fibrosis[1]

Boehringer Ingelheim today announced that the European Commission (EC) has approved an additional indication for nintedanib in adults for the treatment of other chronic fibrosing interstitial lung dis

July 14, 2020 21:05

HD Medical Awarded FDA Clearance For HD Steth

HD Medical, Inc. of Silicon Valley today announces that its flagship product, HD Steth, has received FDA clearance for all three product classification codes of DQD, DQC and DPS for Electronic Stethos

July 14, 2020 14:25

New Data to Be Presented at the ISTH 2020 Virtual Congress Demonstrating Octapharma’s Commitment to Patients With Bleeding Disorders

Octapharma announced today that new research findings from its haematology portfolio will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress, taki

July 14, 2020 11:40

Allscripts and Microsoft Extend Strategic Alliance to Transform Cloud-Based Health IT Solutions

Today Allscripts (MDRX: NASDAQ) and Microsoft Corp. announced the extension of their long-standing strategic alliance to enable the expanded development and delivery of cloud-based health IT solutions

July 13, 2020 10:09

Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders

Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502/NYSE:TAK) today announced that 13 abstracts are being presented from the company’s Hematology portfolio and pipeline at the International So

July 10, 2020 17:25

Laboratory Studies Confirm BETADINE® Antiseptic Products’ Effectiveness Against COVID-19 Virus

Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SAR

July 10, 2020 17:10

New Evidence Shows Morinaga Milk’s Probiotic Bifidobacterium breve A1 Improves Memory of Older Adults With Cognitive Dysfunction

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve

July 10, 2020 10:27

Perceived burden of disease is greater in younger people living with COPD, global survey reveals

Results of a global survey of 1,375 adults aged at least 45 years old and living with Chronic Obstructive Pulmonary Disease (COPD) in 11 countries have been published in COPD: Journal of Chronic Obstr

July 10, 2020 10:00

DRADS Capital Leads Series C Round for ROKIT Healthcare

DRADS Capital announced its investment in ROKIT Healthcare Inc., a South Korean biotechnology company developing innovative 4D bioprinting techniques and applications, in its Series C funding round of

July 09, 2020 22:00

New AMR Action Fund Steps in to Save Collapsing Antibiotic Pipeline With Pharmaceutical Industry Investment of US$1 Billion

Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund [www.AMRactionfund.com], a ground-breaking partnership that aims to bring 2-4 new antibiotics to pat

July 09, 2020 14:25

Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners

Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) and the New York Academy of Sciences announced today the Winners of the third annual Innovators in Science Award for their excellen

July 08, 2020 08:53

Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases

Boehringer Ingelheim and Numab Therapeutics (Numab) today announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects aiming at no

July 07, 2020 13:15

Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp®

Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients

July 03, 2020 14:00

EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome

EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced that the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-co

July 03, 2020 13:30

Urethral Stricture Treatment by Hybrid Cell Therapy, Granted Japanese Patent

Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients

July 02, 2020 15:20

Smiths Detection enters into agreement to acquire PathSensors to expand its biological-detection capability

Smiths Detection, a global leader in detection and screening technologies, today announces that it has entered into an agreement to acquire PathSensors, a leading bio-technology solutions and environm

July 01, 2020 17:55

Laboratory Studies Confirm the Effectiveness of BETADINE® Gargle and Mouthwash Against COVID-19 Virus

Laboratory testing completed at the Tropical Infectious Diseases Research and Education Center (TIDREC) at the University of Malaya, Malaysia, has confirmed the effectiveness of BETADINE® Gargle and M

June 30, 2020 13:55

PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in Europe

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced the completion of the expansion of its new Biotech Center of Excellence

June 30, 2020 09:00

GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA) on its Clinical Development and Biomanufacturing Strategy for Acute Liver Failure

GoLiver Therapeutics, a start-up focused on the development of Innovative Therapy Medicines, in particular cell therapy products for life-threatening liver diseases without the need for transplant usi

June 29, 2020 18:00

Teijin Receives Marketing Approval for Merz’s Xeomin® Botulinum Toxin Type A in Japan

Merz Pharmaceuticals GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly an

June 25, 2020 16:45

London Scientific Researchers Publish Study Proving the Quality of Bovine Colostrum Sourcing Can Significantly Impact Health Benefits

A newly published study from scientific researchers based at University of Plymouth, UK, Queen Mary University of London and colostrum-based nutrition company, PanTheryx of Boulder, Colorado reveals t

June 23, 2020 17:00

Illumina’s Noninvasive Prenatal Screening Kit Receives Regulatory Approval in S. Korea

On June 23, 2020, Illumina, a global leader in DNA sequencing and array-based technologies, announced it has received regulatory approval from South Korea’s Ministry of Food and Drug Safety (MFDS) of

June 23, 2020 11:25

Japanese Dietary Supplement: Nichi Glucan, an Immune Booster in Covid-19

A unique Beta 1,3-1,6 Glucan based Japanese health supplement, produced by black yeast, Aureobasidium Pullulans, could strategically help tackle Covid-19 in people with comorbid conditions like diabet

News by Region

News by Industry